Blood cancer drugs

These companies develop or sell drugs and cell therapies that treat leukemia, lymphoma, myeloma and other blood cancers.
−5.4%
over 3 months · S&P 500 −2.1%

Key indicators

Health
49 / 100
Fragile
Solid
Price
P/E 27
Cheap
Expensive
Up over 1 year
11 of 20
Volatility
71%
Calm
Choppy
Health and price: against the other tags.